Diabetes mellitus (DM) appears to be an independent predictor of disease recurrence and progression among patients with non-muscle invasive bladder cancer (NMIBC), according to investigators.

Diabetes is a significant predictor of tumor recurrence after potentially curative therapy for hepatocellular carcinoma in patients with nonviral hepatitis.

Hepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal.

In patients with type 2 diabetes, GLP-1 agonist therapy is associated with decreased risk for AF recurrence following ablation for AF.

Cite this: Diabetes Mellitus Worsens the Recurrence Rate After Potentially Curative Therapy in Patients with Hepatocellular Carcinoma Associated with Nonviral Hepatitus - Medscape - Nov 01, 2008.